Page last updated: 2024-10-29

indolepropanol phosphate and Brain Neoplasms

indolepropanol phosphate has been researched along with Brain Neoplasms in 1 studies

indolepropanol phosphate: binds specifically to the alpha subunit, but not to the beta subunit of tryptophan synthase
3-(indol-3-yl)propyl phosphate : An monoalkyl phosphate compound having an O-3-(indol-3-yl)propyl substituent.

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lee, SH1
Kwon, HJ1
Park, S1
Kim, CI1
Ryu, H1
Kim, SS1
Park, JB1
Kwon, JT1

Other Studies

1 other study available for indolepropanol phosphate and Brain Neoplasms

ArticleYear
Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP downregulates stemness phenotype and mesenchymal trans-differentiation after irradiation in glioblastoma multiforme.
    PloS one, 2021, Volume: 16, Issue:9

    Topics: Animals; Brain Neoplasms; Cell Proliferation; Glioblastoma; Humans; Immunohistochemistry; Indoles; M

2021